Longitudinal Dosing Patterns and Treatment Costs Among Patients with Spinal Muscular Atrophy Initiating Nusinersen and Risdiplam.

Toro Jimenez W, Yang M, Song W, Lemus Wirtz E, Ye D

Open source

DOI
10.1007/s12325-026-03687-0
Published
2026 Aug 6
Container
Advances in therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12325-026-03687-0,
  title = {Longitudinal Dosing Patterns and Treatment Costs Among Patients with Spinal Muscular Atrophy Initiating Nusinersen and Risdiplam.},
  author = {Toro Jimenez W and Yang M and Song W and Lemus Wirtz E and Ye D},
  year = {2026},
  journal = {Advances in therapy},
  doi = {10.1007/s12325-026-03687-0},
  url = {https://doi.org/10.1007/s12325-026-03687-0}
}

RIS

TY  - JOUR
TI  - Longitudinal Dosing Patterns and Treatment Costs Among Patients with Spinal Muscular Atrophy Initiating Nusinersen and Risdiplam.
AU  - Toro Jimenez W
AU  - Yang M
AU  - Song W
AU  - Lemus Wirtz E
AU  - Ye D
PY  - 2026
JO  - Advances in therapy
DO  - 10.1007/s12325-026-03687-0
UR  - https://doi.org/10.1007/s12325-026-03687-0
ER  - 

APA

W, T. J., M, Y., W, S., E, L. W., & D, Y. (2026). Longitudinal Dosing Patterns and Treatment Costs Among Patients with Spinal Muscular Atrophy Initiating Nusinersen and Risdiplam.. Advances in therapy. https://doi.org/10.1007/s12325-026-03687-0

Source records